Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma

Pediatric Blood and Cancer

Volumn 47, Issue 5, 2006, Pages 607-611

  Furth, C ^a   Amthauer, H ^a   Denecke, T ^a   Ruf, J ^a   Henze, G ^a   Gutberlet, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ewing sarcoma; Pediatric; Positron emission tomography; Response; Staging; Whole body MRI

Indexed keywords

DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE LESION; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EWING SARCOMA; FEMALE; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ADOLESCENT; BONE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SARCOMA, EWING'S; SENSITIVITY AND SPECIFICITY;

EID: 33748513270     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20662     Document Type: Article

References (22)

1. German Childhood Cancer Registry, Mainz. Annual Report 2004. http://info.imsd.uni-mainz.de/K_Krebsregister/english. Cited Jan 13 2004.
2. Kovar H. Ewing's sarcoma and peripherial primitive neuroectodermal tumours after their genetic union. Curr Opin Oncol 1998;10:342.
3. Creutzig U, Klußmann JH. Von tödlichen zu heilbaren Erkrankungen. Die Erfolge der pädiatrischen Onkologie in den letzten 25 Jahren. GPHO & Kompetenznetz Pädiatrische Hämatologie und Onkologie www.kinderkrebsinfo.de/e1664/e1676/e7099/Erfolgstory_2002-11- 22_secured_ger.pdf. Cited Nov 22 2002.
4. EURO-E.W.I.N.G.99, Münster. Euro-E.W.I.N.G.99 main protocol. http://euro-ewing.uni-muenster.de/ewing99.html. Cited Feb 20 2004.
5. Marec-Bérard P, Phillip T. Part of Proceedings Ewing-sarcoma: The pediatrican's point of view. Pediatr Blood Cancer 2004;42:477-480.
6. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818-1829.
7. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection bone metastases in children in young adults: Comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001;177:229-236.
8. Shulkin BL, Mitchell DS, Ungar DR, et al. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995;194:495-500.
9. Mazumdar A, Siegel MJ, Narra V, et al. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: A pilot study. AJR Am J Roentgenol 2002;179:1261-1266.
10. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002;12:2091-2099.
11. Franzius C, Sciuk J, Brinkschmidt C, et al. Evaluation of chemotherapy response in primary bone tumours with F-18 FDG positron emission tomography compared with histologically assessed tumour necrosis. Clin Nucl Med 2000;25:874-881.
12. Voelker T, Furth C, Amthauer H, et al. Value of FDG-PET imaging for primary staging and follow-up of malignant sarcoma in childhood. Eur J Nucl Med Mol Imaging 2004;31:p271.
13. Mentzel HJ, Kentouche K, Sauner D, et al. Comparison of whole-body STIR-MRI and technetium 99m-methylene diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 2004;14:2297-3022.
14. Moore S, Dawson K. Red and yellow marrow in the femor: Age related changes in appearance at MRI. Radiology 1999;175:219-223.
15. Eustace S, Tello R, DeCarvalho V, et al. A comparison of whole-body turbo short tau inversion recovery MR imaging and planar technetium 99m-methylene diphosphonate scintigraphy in the evaluation of patients with suspected skeletal metastases. AJR Am J Roentgenol 1997;169:1655-1661.
16. Hargaden G, O'Connell MJ, Kavanagh E, et al. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. AJR Am J Roentgenol 1003;180:247-252.
17. Kavanagh E, Smith C, Eustace S. Whole body turbo STIR-MR imaging: Controversies and avenues for development. Eur Radiol 2003;13:2196-2205.
18. Franzius C, Daldrup-Link HE, Wagner-Bohn A, et al. FDG-PET for detection of recurrences from malignant bone tumours: Comparison with conventional imaging. Ann Oncol 2002;13:157-160.
19. McCarville MB, Christie R, Daw NC, et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005;184:1293-1304.
20. Mazumdar M, Smith A, Schwartz LH. A statistical simulation study finds discordance between WHO criteria and RECIST guideline. J Clin Epidemiol 2004;57:358-365.
21. van der Woude HJ, Bloem JL, Hogendoorn PC. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: Review of current imaging modalities. Skeletal Radiol 1998;27:57-71.
22. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999;35:1773-1782.